| 421 | Responsible Conduct of Research | | 01/11/2021 14:59:34 | |
| 422 | Responsible Conduct of Research | | 01/11/2021 15:05:18 | |
| 423 | Good Clinical Practice Course for Clinical Trials Involving Drugs (ICH focus) | | 01/11/2021 15:06:03 | |
| 424 | CITI/2021 | | 01/11/2021 15:11:47 | |
| 425 | CITI Program course | | 01/11/2021 15:12:13 | |
| 426 | Good Clinical Practice (U.S. FDA Focus) | | 01/11/2021 15:12:21 | |
| 427 | Good Clinical Practice (U.S. FDA Focus) | | 01/11/2021 15:13:10 | |
| 428 | GCP | | 01/11/2021 15:13:26 | |
| 429 | Good Clinical Practice Course for Clinical Trials Involving Devices (international focus) | | 01/11/2021 15:13:59 | |
| 430 | Responsible Conduct of Research | | 01/11/2021 15:14:50 | |
| 431 | Residents, Research nurse, Students - Basic/Refresher | | 01/11/2021 15:15:32 | |
| 432 | CITI Conflicts of Interest | | 01/11/2021 15:16:16 | |
| 433 | GCP | | 01/11/2021 15:27:27 | |
| 434 | CITI program training | | 01/11/2021 18:13:45 | |
| 435 | Human subject protection course & GCP | | 01/11/2021 19:39:17 | |
| 436 | GCP Training Course 4.0 | | 01/11/2021 21:50:48 | |
| 437 | Hepato-pancreato-biliary fellowship | | 02/11/2021 07:53:16 | |
| 438 | Citi program | | 02/11/2021 08:50:07 | |
| 439 | CITI program | | 29/06/2024 11:03:17 | |
| 440 | ICH GOOD CLINICAL PRACTICE E6 (R2) | | 02/11/2021 10:35:04 | |
